A study analysing impact of the gut microbiome on T-cell based immunotherapies
Latest Information Update: 27 Jan 2022
At a glance
- Drugs Axicabtagene ciloleucel (Primary) ; Tisagenlecleucel (Primary)
- Indications Chronic lymphocytic leukaemia; Diffuse large B cell lymphoma; Follicular lymphoma; Mantle-cell lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 14 Dec 2021 Results (n=23)presented at the 63rd American Society of Hematology Annual Meeting and Exposition
- 11 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology